Advertisement
Loading...

Goldman Sachs Access Treasury 0-1 Year ETF

GBILAMEX
Financial Services
Asset Management
$100.11
$0.02(0.02%)
U.S. Market opens in 1h 7m
Advertisement

GBIL News Today: Stay Updated with the Latest Goldman Sachs Access Treasury 0-1 Year ETF News in Real Time

Find GBIL news now at Meyka AI. Stay informed with the latest Goldman Sachs Access Treasury 0-1 Year ETF stocks updates, including price news, market analysis, and expert insights.

Sydney Gang Boss Shot Dead in Vietnam: May 26 Arrests
📅 in about 5 hours

Sydney Gang Boss Shot Dead in Vietnam: May 26 Arrests

Two arrested in Vietnam over shooting death of Sydney gangster Lorenzo Lemalu on May 26. CCTV shows gunman open fire at Ho Chi Minh City restaurant.

Read more
IonQ Stock (NYSE: IONQ) Surges 8.07% to $63.64 as $2B U.S. Quantum Funding and Strong Q1 Results Boost Sentiment
📅 in about 5 hours

IonQ Stock (NYSE: IONQ) Surges 8.07% to $63.64 as $2B U.S. Quantum Funding and Strong Q1 Results Boost Sentiment

IonQ stock jumped 8.07% to $63.64 after the quantum computing company posted another strong earnings quarter in May 2026. The rally came as investors reacted to record Q1 revenue growth, higher full-year guidance, and fresh reports about a proposed $2 billion U.S. quantum technology funding push. IonQ reported $64.7 million in quarterly revenue, up 755%…

Read more
Swiss Chocolate Tariffs May 26: Tariff Crisis Threatens Industry
📅 in about 4 hours

Swiss Chocolate Tariffs May 26: Tariff Crisis Threatens Industry

Swiss chocolate industry faces tariff crisis on May 26. Lindt cuts prices 20%, consumption falls 2.7% amid trade tensions.

Read more
ASTS Stock Jumps 10.01% as AST SpaceMobile Hits $105.86 on Strong Institutional Demand
📅 in about 4 hours

ASTS Stock Jumps 10.01% as AST SpaceMobile Hits $105.86 on Strong Institutional Demand

AST SpaceMobile saw a sharp rise in market value as asts stock jumped 10.01%, pushing the share price to $105.86 during recent trading sessions. The surge reflects increasing confidence from institutional investors who are positioning themselves in the fast-growing satellite-to-mobile communications industry. The rally comes at a time when global demand for direct-to-smartphone satellite connectivity…

Read more
BHP Stock May 26: Record High Driven by Board Shake-Up
📅 in about 4 hours

BHP Stock May 26: Record High Driven by Board Shake-Up

BHP shares hit record highs on May 26 as Mark Vassella joins the board. Stock up 31% YTD and 56% in 12 months. Explore what’s driving the rally.

Read more
Rahul Gandhi May 26: BJP Slams Opposition Leader’s Modi Govt Prediction
📅 in about 4 hours

Rahul Gandhi May 26: BJP Slams Opposition Leader’s Modi Govt Prediction

Rahul Gandhi predicts Modi government collapse within one year, sparking BJP criticism and political controversy over opposition leader’s remarks.

Read more
BHP Stock May 26: Net Zero Pledge Under Fire
📅 in about 3 hours

BHP Stock May 26: Net Zero Pledge Under Fire

BHP’s leaked documents reveal only 1% emissions cuts by 2030, contradicting its net zero 2050 pledge and raising credibility concerns.

Read more
High Dividend Stocks in the United States (May 2026): NSTB, NSTB-UN, NSTB-WT & CYA, Full Market Data, Prices & Returns
📅 in about 3 hours

High Dividend Stocks in the United States (May 2026): NSTB, NSTB-UN, NSTB-WT & CYA, Full Market Data, Prices & Returns

Dividend Stocks remain one of the most searched investment categories in May 2026 as investors continue looking for stable income and better portfolio protection. Many traders and long-term investors now prefer companies that can offer both growth opportunities and regular payouts during uncertain market conditions. The US stock market has become more selective this year….

Read more
Eli Lilly And Co Hits $1,065 as UBS Highlights 28% Weight Loss Results From Retatrutide Study
📅 in about 3 hours

Eli Lilly And Co Hits $1,065 as UBS Highlights 28% Weight Loss Results From Retatrutide Study

Eli Lilly and Company has reached a major milestone as its stock price climbed to $1,065.00, driven by renewed investor optimism following strong clinical trial results for its experimental obesity drug Retatrutide. The surge reflects growing confidence in the company’s long-term growth pipeline and its leadership in the global weight-loss drug market. The latest update…

Read more

GBIL News FAQ